Page 27 - Reliance Industries

Top headlines: Govt to list SOP for IT rules; Jet Airways assured of slots

Top headlines at this hour: Companies raise prices as input costs rise; Jet Airways new owners hear good news from airports.

Will the Chairman of Saudi Aramco join RIL's board? Wait for mega AGM

An announcement of Al-Rumayyan's induction on the RIL board or the board of the newly carved oil-to-chemical (O2C) unit may come as early as at the company's annual shareholder meeting on June 24

Tech promoters top list of cash recipients; family-owned groups earn less

Reliance Industries' Mukesh Ambani is fourth on the list in terms of income earned (dividend) from his company in 2020-21 (FY21)

Limited coverage: Few analysts track Adani group companies, shows data

The Adani group has five listed entities, and the median number of analysts covering the group is one, lower than that of other large groups

New Reliance Industries' partly paid shares commence trading on NSE

Trading in the earlier version of RIL PP shares was suspended on May 11.

Reliance Industry says Jamnagar unit shut since June 6, may hit exports

The refinery is part of the world's biggest refining complex in the city of Jamnagar in Gujarat

Sensex slumps 334 points as bears return; RIL, bank stocks decline

Domestic markets surrendered early gains to finish deep in the red on Wednesday as profit-booking emerged in Reliance Industries, banking and infra stocks amid a weak trend in global equities. Concerns over frothy valuations and a depreciating rupee also sapped investor confidence, traders said. After a firm opening, the 30-share BSE Sensex suddenly succumbed to selling pressure in mid-afternoon trade. It finally closed 333.93 points or 0.64 per cent lower at 51,941.64, extending its losing streak to the second session. On similar lines, the broader NSE Nifty slumped 104.75 points or 0.67 per cent to end at 15,635.35. L&T was the top loser among the Sensex companies, shedding 1.80 per cent, followed by Reliance Industries, Bajaj Finserv, IndusInd Bank, Bajaj Finance, SBI, Maruti, Axis Bank and Bajaj Auto. On the other hand, PowerGrid, NTPC, Titan, HCL Tech and Asian Paints were among the gainers, spurting up to 3.42 per cent. "Domestic equities fell sharply as selling pressure in

Sensex, Nifty end marginally lower; HDFC twins, Reliance Industries weigh

The 30-share BSE Sensex slipped 52.94 points or 0.10 per cent to 52,275.57. The broader NSE Nifty declined 11.55 points or 0.07 per cent to 15,740.10

Sensex, Nifty scale fresh peaks; Reliance Industries leads charge

A sharp recovery in the rupee added to the momentum, even as lacklustre global cues capped the gains, traders said

Value of India's top 100 brands up 2% in 2021; Tata Group most valuable

Among the brands that came on the top of the list include Tata Group, Reliance Industries, and Mahindra Group

Govt challenges Panna-Mukta field arbitration before English High Court

The government has challenged an arbitration award over a cost recovery dispute in the western offshore Panna-Mukta and Tapti oil and gas fields of Shell and Reliance Industries Ltd.

Reliance Foundation seeks nod to import J&J doses for its workforce

Reliance Foundation is the philanthropic arm of the Mukesh Ambani-led Reliance Industries

SoftBank Group may invest $700 mn in Flipkart after exiting firm in 2018

Techy conglomerate investing in Flipkart at a time when Reliance Industries and Tata are betting big on e-commerce as well.

Top Headlines: RBI likely to hold interest rates; Softbank to back Flipkart

Our top headlines on Friday track the latest developments

Amid pandemic, chairman Mukesh Ambani drew no salary in FY21: Reliance

In the previous fiscal year, he drew a Rs 15 cr salary from the company - the same as in the previous 11 years

Reliance Industries set for windfall gain from oil and gas vertical

According to Harsh Dole, vice-president of IIFL, the commercialisation of key gas discoveries of RIL are no less than a game changer

Reliance submits proposal for potential coronavirus drug Niclosamide

Reliance Industries Ltd's R&D arm has proposed the use of Niclosamide - the drug used to treat tapeworm infestation - for treating COVID-19 patients. Niclosamide, a drug on the World Health Organisation's list of essential medicines, has been used to treat tapeworm infestation for more than 50 years. The oral antiviral drug was also used to treat patients during the SARS outbreak of 2003-04. "The company submitted a proposal for the application of Niclosamide as a potential drug against COVID-19," the firm's latest annual report said. The drug regulator will now evaluate the proposal for public use. The company however did not say if it plans to manufacture the drug or would use it to treat COVID patients at hospitals run by the group. The Indian government has already given clearance for the Phase 2 clinical trials of Niclosamide in COVID-19 treatment in adult patients. The Reliance R&D (research and development) team is also working with various Council of Scientific & ..

Tapeworm drug, masks are part of Reliance's plan to tackle coronavirus

Reliance Industries is exploring use of a tapeworm drug, Niclosamide, as a cure for Covid-19, according to its annual report.

Reliance Industries rallies 15% in seven days, hits over 7-month high

The stock was up 2.2 per cent at Rs 2,250 on the BSE in intra-day trade on Thursday, trading close to its record high level of Rs 2,368.80 touched on September 16, 2020

RIL to provide financial support to families of employees who died of Covid

Reliance Industries has said that it will continue to provide salaries for five years to the nominee of employees who succumbed to the disease